These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37295840)

  • 21. Attitude towards and perception of individual safety after SARS-CoV-2 vaccination among German cancer patients.
    Overheu O; Lendowski S; Quast DR; Marheinecke CS; Kourti E; Lugnier C; Andreica I; Kiltz U; Pfaender S; Reinacher-Schick A
    J Cancer Res Clin Oncol; 2023 May; 149(5):1985-1992. PubMed ID: 35731276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring vaccination coverage and attitudes of health care workers towards influenza vaccine in Cyprus.
    Papageorgiou C; Mazeri S; Karaiskakis M; Constantinou D; Nikolaides C; Katsouris S; Patsalou M; Kourouzidou D; Pantelas G; Koliou M
    Vaccine; 2022 Mar; 40(12):1775-1782. PubMed ID: 35168841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding facilitators and barriers to COVID-19 vaccination in the Zimbabwean population: a qualitative analysis.
    Midzi N; Mutsaka-Makuvaza MJ; Charimari LS; Mangwiro P; Manengureni T; Mugadza G
    BMC Public Health; 2024 Apr; 24(1):1174. PubMed ID: 38679733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza Virus and SARS-CoV-2 Vaccines.
    Sandor AM; Sturdivant MS; Ting JPY
    J Immunol; 2021 Jun; 206(11):2509-2520. PubMed ID: 34021048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Influenza Vaccination on Risk of Coronavirus Disease 2019: A Prospective Cohort Study of 46 000 Healthcare Workers.
    Kristensen JH; Bo Hasselbalch R; Pries-Heje M; Nielsen PB; Dehlbæk Knudsen A; Fogh K; Boesgaard Norsk J; Eiken A; Andersen O; Fischer TK; Juul Jensen CA; Torp-Pedersen C; Rungby J; Ditlev SB; Hageman I; Møgelvang R; Gybel-Brask M; Dessau RB; Sørensen E; Harritshøj L; Folke F; Engel Møller ME; Benfield T; Ullum H; Sværke Jørgensen C; Rye Ostrowski S; Dam Nielsen S; Bundgaard H; Iversen K
    J Infect Dis; 2022 Aug; 226(1):6-10. PubMed ID: 34989811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine.
    Spinelli FR; Favalli EG; Garufi C; Cornalba M; Colafrancesco S; Conti F; Caporali R
    Arthritis Res Ther; 2022 Jan; 24(1):21. PubMed ID: 35016701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attitudes Toward COVID-19 Illness and COVID-19 Vaccination among Pregnant Women: A Cross-Sectional Multicenter Study during August-December 2020.
    Battarbee AN; Stockwell MS; Varner M; Newes-Adeyi G; Daugherty M; Gyamfi-Bannerman C; Tita AT; Vorwaller K; Vargas C; Subramaniam A; Reichle L; Galang RR; Powers E; Lucca-Susana M; Parks M; Chen TJ; Razzaghi H; Dawood FS
    Am J Perinatol; 2022 Jan; 39(1):75-83. PubMed ID: 34598291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza vaccination in coronavirus times: Primary Care professionals' intention to get vaccinated in Central Catalonia (VAGCOVID). A cross sectional study.
    Muñoz-Miralles R; Bonet-Esteve A; Rufas-Cebollero A; Fuster-Casanovas A; Pelegrin-Cruz X; Vidal-Alaball J
    Hum Vaccin Immunother; 2022 Nov; 18(5):2067442. PubMed ID: 35776921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists.
    Santosa A; Xu C; Arkachaisri T; Kong KO; Lateef A; Lee TH; Leong KH; Low AHL; Sriranganathan MK; Tan TC; Teng GG; Thong BY; Fong W; Lahiri M
    Int J Rheum Dis; 2021 Jun; 24(6):746-757. PubMed ID: 33973379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza vaccination and COVID-19 infection risk and disease severity: A systematic review and multilevel meta-analysis of prospective studies.
    Del Riccio M; Caini S; Bonaccorsi G; Lorini C; Paget J; van der Velden K; Cosma C
    Am J Infect Control; 2024 Sep; 52(9):1091-1098. PubMed ID: 38768817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parents' intent to vaccinate against influenza during the COVID-19 pandemic im two regions in Switzerland.
    Seiler M; Goldman RD; Staubli G; Hoeffe J; Gualco G; Manzano S
    Swiss Med Wkly; 2021 May; 151():w20508. PubMed ID: 35275392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hesitancy for receiving regular SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis from the UK-REACH study.
    Veli N; Martin CA; Woolf K; Nazareth J; Pan D; Al-Oraibi A; Baggaley RF; Bryant L; Nellums LB; Gray LJ; Khunti K; Pareek M;
    BMC Med; 2022 Oct; 20(1):386. PubMed ID: 36210437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists.
    Priori R; Pellegrino G; Colafrancesco S; Alessandri C; Ceccarelli F; Di Franco M; Riccieri V; Scrivo R; Sili Scavalli A; Spinelli FR; Conti F
    Ann Rheum Dis; 2021 Jul; 80(7):953-954. PubMed ID: 33622689
    [No Abstract]   [Full Text] [Related]  

  • 35. SARS-CoV-2 vaccine uptake and reasons for hesitancy among Canadian pregnant people: a prospective cohort study.
    Gorgui J; Atallah A; Boucoiran I; Gomez YH; Bérard A;
    CMAJ Open; 2022; 10(4):E1034-E1043. PubMed ID: 36735245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar.
    Tayar E; Abdeen S; Abed Alah M; Chemaitelly H; Bougmiza I; Ayoub HH; Kaleeckal AH; Latif AN; Shaik RM; Al-Romaihi HE; Al-Thani MH; Bertollini R; Abu-Raddad LJ; Al-Khal A
    J Infect Public Health; 2023 Feb; 16(2):250-256. PubMed ID: 36603377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza vaccination during the coronavirus pandemic: intention to vaccinate among the at-risk population in the Central Catalonia Health Region (VAGCOVID).
    Bonet-Esteve A; Muñoz-Miralles R; Gonzalez-Claramunt C; Rufas AM; Cruz XP; Vidal-Alaball J
    BMC Fam Pract; 2021 May; 22(1):84. PubMed ID: 33931039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study.
    Szebeni GJ; Gémes N; Honfi D; Szabó E; Neuperger P; Balog JÁ; Nagy LI; Szekanecz Z; Puskás LG; Toldi G; Balog A
    Front Immunol; 2022; 13():846248. PubMed ID: 35432314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination against influenza viruses reduces infection, not hospitalization or death, from respiratory COVID-19: A systematic review and meta-analysis.
    Pontiroli AE; Scovenna F; Carlini V; Tagliabue E; Martin-Delgado J; La Sala L; Tanzi E; Zanoni I
    J Med Virol; 2024 Jan; 96(1):e29343. PubMed ID: 38163281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of COVID-19 Infection in People Previously Vaccinated Against Influenza: Population-Based Cohort Study Using Primary Health Care Electronic Records.
    Giner-Soriano M; de Dios V; Ouchi D; Vilaplana-Carnerero C; Monteagudo M; Morros R
    JMIR Public Health Surveill; 2022 Nov; 8(11):e36712. PubMed ID: 36265160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.